ANIK Annual Total Long Term Liabilities
$27.31 M
-$8.34 M-23.40%
31 December 2023
Summary:
As of January 20, 2025, ANIK annual total long term liabilities is $27.31 million, with the most recent change of -$8.34 million (-23.40%) on December 31, 2023. During the last 3 years, it has fallen by -$29.03 million (-51.53%). ANIK annual total long term liabilities is now -51.53% below its all-time high of $56.34 million, reached on December 31, 2020.ANIK Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIK Quarterly Long Term Liabilities
$26.05 M
-$148.00 K-0.56%
30 September 2024
Summary:
As of January 20, 2025, ANIK quarterly total long term liabilities is $26.05 million, with the most recent change of -$148.00 thousand (-0.56%) on September 30, 2024. Over the past year, it has dropped by -$3.56 million (-12.02%). ANIK quarterly long term liabilities is now -79.02% below its all-time high of $124.17 million, reached on June 30, 2020.ANIK Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIK Long Term Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -23.4% | -12.0% |
3 y3 years | -51.5% | -23.6% |
5 y5 years | +567.4% | -2.5% |
ANIK Long Term Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -23.4% | at low | -32.4% | at low |
5 y | 5-year | -51.5% | +4.8% | -79.0% | at low |
alltime | all time | -51.5% | >+9999.0% | -79.0% | >+9999.0% |
Anika Therapeutics Long Term Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sept 2024 | - | $26.05 M(-0.6%) |
June 2024 | - | $26.20 M(-2.1%) |
Mar 2024 | - | $26.75 M(-2.1%) |
Dec 2023 | $27.31 M(-23.4%) | $27.31 M(-7.8%) |
Sept 2023 | - | $29.61 M(-5.7%) |
June 2023 | - | $31.41 M(-4.2%) |
Mar 2023 | - | $32.79 M(-8.0%) |
Dec 2022 | $35.65 M(+16.3%) | $35.65 M(-2.2%) |
Sept 2022 | - | $36.46 M(-5.4%) |
June 2022 | - | $38.54 M(+30.8%) |
Mar 2022 | - | $29.46 M(-3.9%) |
Dec 2021 | $30.66 M(-45.6%) | $30.66 M(-10.1%) |
Sept 2021 | - | $34.10 M(-2.5%) |
June 2021 | - | $34.96 M(-9.5%) |
Mar 2021 | - | $38.62 M(-31.4%) |
Dec 2020 | $56.34 M(+116.2%) | $56.34 M(-44.1%) |
Sept 2020 | - | $100.75 M(-18.9%) |
June 2020 | - | $124.17 M(+57.1%) |
Mar 2020 | - | $79.03 M(+203.3%) |
Dec 2019 | $26.05 M(+536.7%) | $26.05 M(-2.4%) |
Sept 2019 | - | $26.70 M(+2.6%) |
June 2019 | - | $26.03 M(+0.2%) |
Mar 2019 | - | $25.99 M(+535.0%) |
Dec 2018 | $4.09 M(-32.4%) | $4.09 M(-12.8%) |
Sept 2018 | - | $4.69 M(-25.2%) |
June 2018 | - | $6.28 M(-2.6%) |
Mar 2018 | - | $6.45 M(+6.5%) |
Dec 2017 | $6.05 M(-30.2%) | $6.05 M(-25.6%) |
Sept 2017 | - | $8.14 M(+9.6%) |
June 2017 | - | $7.42 M(+4.3%) |
Mar 2017 | - | $7.12 M(-17.9%) |
Dec 2016 | $8.67 M(+13.8%) | $8.67 M(-2.9%) |
Sept 2016 | - | $8.93 M(+14.5%) |
June 2016 | - | $7.80 M(-5.2%) |
Mar 2016 | - | $8.22 M(+7.9%) |
Dec 2015 | $7.62 M(-12.8%) | $7.62 M(-22.6%) |
Sept 2015 | - | $9.85 M(+3.8%) |
June 2015 | - | $9.49 M(-2.3%) |
Mar 2015 | - | $9.71 M(+11.2%) |
Dec 2014 | $8.74 M(-21.5%) | $8.74 M(-6.6%) |
Sept 2014 | - | $9.36 M(-0.2%) |
June 2014 | - | $9.38 M(-4.1%) |
Mar 2014 | - | $9.78 M(-12.1%) |
Dec 2013 | $11.13 M(-40.5%) | $11.13 M(-39.3%) |
Sept 2013 | - | $18.32 M(+6.1%) |
June 2013 | - | $17.26 M(-3.0%) |
Mar 2013 | - | $17.79 M(-4.8%) |
Dec 2012 | $18.69 M(-20.6%) | $18.69 M(-2.9%) |
Sept 2012 | - | $19.24 M(-5.7%) |
June 2012 | - | $20.41 M(-7.6%) |
Mar 2012 | - | $22.09 M(-6.2%) |
Dec 2011 | $23.54 M(-3.4%) | $23.54 M(+8.1%) |
Sept 2011 | - | $21.79 M(-4.8%) |
June 2011 | - | $22.88 M(-1.0%) |
Mar 2011 | - | $23.11 M(-5.2%) |
Date | Annual | Quarterly |
---|---|---|
Dec 2010 | $24.38 M(-20.8%) | $24.38 M(-10.2%) |
Sept 2010 | - | $27.15 M(-2.3%) |
June 2010 | - | $27.79 M(-7.3%) |
Mar 2010 | - | $29.98 M(-2.5%) |
Dec 2009 | $30.77 M(+18.2%) | $30.77 M(+34.3%) |
Sept 2009 | - | $22.91 M(-4.2%) |
June 2009 | - | $23.93 M(-4.3%) |
Mar 2009 | - | $25.02 M(-3.9%) |
Dec 2008 | $26.03 M(+87.3%) | $26.03 M(+32.8%) |
Sept 2008 | - | $19.60 M(-4.0%) |
June 2008 | - | $20.42 M(+18.4%) |
Mar 2008 | - | $17.25 M(+24.1%) |
Dec 2007 | $13.90 M(-19.0%) | $13.90 M(-24.6%) |
Sept 2007 | - | $18.43 M(+3.5%) |
June 2007 | - | $17.80 M(+7.1%) |
Mar 2007 | - | $16.62 M(-3.1%) |
Dec 2006 | $17.16 M(-9.2%) | $17.16 M(-3.6%) |
Sept 2006 | - | $17.81 M(-3.8%) |
June 2006 | - | $18.51 M(+1.6%) |
Mar 2006 | - | $18.23 M(-3.6%) |
Dec 2005 | $18.90 M(-15.0%) | $18.90 M(-3.4%) |
Sept 2005 | - | $19.57 M(-3.3%) |
June 2005 | - | $20.25 M(-5.7%) |
Mar 2005 | - | $21.47 M(-3.4%) |
Dec 2004 | $22.23 M(+1134.8%) | $22.23 M(+10.1%) |
Sept 2004 | - | $20.19 M(+7.9%) |
June 2004 | - | $18.70 M(-2.9%) |
Mar 2004 | - | $19.25 M(+969.4%) |
Dec 2003 | $1.80 M(-36.0%) | $1.80 M(-32.1%) |
June 2000 | - | $2.65 M(-2.8%) |
Mar 2000 | - | $2.73 M(-3.1%) |
Dec 1999 | $2.81 M(+2711.1%) | $2.81 M(+2711.1%) |
Dec 1998 | $100.00 K(0.0%) | $100.00 K(-50.0%) |
Mar 1998 | - | $200.00 K(+100.0%) |
Dec 1997 | $100.00 K(0.0%) | $100.00 K(0.0%) |
Sept 1997 | - | $100.00 K(-50.0%) |
June 1997 | - | $200.00 K(+100.0%) |
Mar 1997 | - | $100.00 K(0.0%) |
Dec 1996 | $100.00 K(-66.7%) | - |
Nov 1996 | - | $100.00 K(-66.7%) |
Aug 1996 | - | $300.00 K(+200.0%) |
Aug 1996 | $300.00 K(-40.0%) | - |
May 1996 | - | $100.00 K(-83.3%) |
Feb 1996 | - | $600.00 K(+20.0%) |
Nov 1995 | - | $500.00 K(0.0%) |
Aug 1995 | $500.00 K(-66.7%) | $500.00 K(-16.7%) |
May 1995 | - | $600.00 K(-60.0%) |
Feb 1995 | - | $1.50 M(0.0%) |
Nov 1994 | - | $1.50 M(0.0%) |
Aug 1994 | $1.50 M(-6.3%) | $1.50 M(-6.3%) |
May 1994 | - | $1.60 M(0.0%) |
Feb 1994 | - | $1.60 M(0.0%) |
Nov 1993 | - | $1.60 M(0.0%) |
Aug 1993 | $1.60 M | $1.60 M(-11.1%) |
May 1993 | - | $1.80 M |
FAQ
- What is Anika Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Anika Therapeutics?
- What is Anika Therapeutics annual total long term liabilities year-on-year change?
- What is Anika Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Anika Therapeutics?
- What is Anika Therapeutics quarterly long term liabilities year-on-year change?
What is Anika Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ANIK is $27.31 M
What is the all time high annual total long term liabilities for Anika Therapeutics?
Anika Therapeutics all-time high annual total long term liabilities is $56.34 M
What is Anika Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ANIK annual total long term liabilities has changed by -$8.34 M (-23.40%)
What is Anika Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ANIK is $26.05 M
What is the all time high quarterly long term liabilities for Anika Therapeutics?
Anika Therapeutics all-time high quarterly total long term liabilities is $124.17 M
What is Anika Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ANIK quarterly total long term liabilities has changed by -$3.56 M (-12.02%)